Ketamine Pharmacokinetics in Children Having Heart Surgery

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

December 31, 2009

Conditions
C.Surgical Procedure; Cardiac
Interventions
DRUG

Ketamine

subject will then receive an intravenous bolus dose of ketamine 2 mg/kg as a rapid intravenous bolus, over less than two minutes just prior to CPB. In the non-CPB patients, ketamine will be administered just prior to the skin incision. All doses will be rounded to the nearest tenth of a milligram. Timed blood samples will be collected at standardized times after the completion of the ketamine infusion and samples will be obtained from an indwelling arterial line. Each blood sample for pharmacokinetic analysis will be 1 mL.

Trial Locations (1)

72202

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
lead

Arkansas Children's Hospital Research Institute

OTHER

NCT00598195 - Ketamine Pharmacokinetics in Children Having Heart Surgery | Biotech Hunter | Biotech Hunter